<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine whether offering home fecal immunochemical tests (FITs) to eligible patients during a high volume <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> vaccination clinic could lead to increased <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> screening (CRCS) rates in a managed care setting </plain></SENT>
<SENT sid="1" pm="."><plain>STUDY DESIGN: Observational study </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: During <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> vaccination clinics in 2008, trained staff provided FITs to patients who were eligible for CRCS (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e>-FIT group) (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e> indicates <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> vaccine) </plain></SENT>
<SENT sid="3" pm="."><plain>Screening outcomes for this cohort of patients were compared with those of a similar group of <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> clinic attendees who were not exposed to the intervention (FLUonly group) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Among eligible participants in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e>-only group (N = 4653), 13.7% completed FIT within 90 days of their <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> vaccine, and in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e>-FIT group (N = 2812), 30.3% completed FIT (P &lt;.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e>-FIT group, 1447 (51.4%) were provided with a FIT kit, and 653 (45.1%) of these patients completed a FIT kit within 90 days </plain></SENT>
<SENT sid="6" pm="."><plain>In multivariate analyses, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e>-FIT group participants were significantly more likely to complete FITs compared with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e>-only group participants (Odds Ratio = 2.76 [95% confidence interval, 2.45-3.11]) </plain></SENT>
<SENT sid="7" pm="."><plain>Overall, the CRCS rate for the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e>-only group increased from 51.5% to 56.3% (increase of 4.8 percentage points), compared with an increase from 49.2% to 63.2% (increase of 14.0 percentage points) in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e>-FIT group (P lt;.0001 for change difference) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FLU</z:e>-FIT Program is feasible to implement in a high volume <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> vaccination clinic conducted in a managed care setting and increases <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> screening activity among eligible <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> vaccination recipients who are reached with the intervention </plain></SENT>
</text></document>